US Patent 9265827 Anti-PDGFR-beta antibodies and uses thereof
Patent 9265827 was granted and assigned to Regeneron Pharmaceuticals on February, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 7, 2014
Date of Patent
February 23, 2016
Patent Applicant
Patent Application Number
14148753
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9265827 Anti-PDGFR-beta antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
